Skip to content

Form 4 filed by ORBIMED ADVISORS LLC

ORBIMED ADVISORS LLC filed this Form 4 on Aspen Neuroscience, Inc. with 11 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-04 23:43:12 UTC.

Accession
0000947871-26-000980
Filed
2026-11-04
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: Aspen Neuroscience, Inc. (CIK 2124080)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-02C converted+196,541196,541I See footnotes
Common Stock 2026-11-02C converted+642,745839,286I See footnotes
Common Stock 2026-11-02C converted+616,9841,456,270I See footnotes
Common Stock 2026-11-02C converted+625,7432,082,013I See footnotes
Common Stock 2026-11-02C converted+507,1192,589,132I See footnotes
Common Stock 2026-11-02P bought+1,000,000$153,589,132I See footnotes
Series Seed-2 Convertible Preferred Stock derivative2026-11-02C converted-196,541$00I See footnotes
Series A-1 Convertible Preferred Stock derivative2026-11-02C converted-642,745$00I See footnotes
Series A-2 Convertible Preferred Stock derivative2026-11-02C converted-616,984$00I See footnotes
Series B Convertible Preferred Stock derivative2026-11-02C converted-625,743$00I See footnotes
Series C Convertible Preferred Stock derivative2026-11-02C converted-507,119$00I See footnotes